Skip to main content
[Preprint]. 2020 Nov 5:2020.06.08.20125989. Originally published 2020 Jun 9. [Version 2] doi: 10.1101/2020.06.08.20125989

Table 1.

Colorado LTCF cohort characteristics.

All participant
(n = 544)
n (%)
v RNA+ participants
(n = 91)
n (%)
Site A 100 (18%) 0 (0%)
B 108 (20%) 8 (9%)
C 51 (9%) 10 (11%)
D 128 (24%) 54 (59%)
E 76 (14%) 14 (15%)
F 81 (15%) 5 (5%)
Total NP swabs tested 3591 179
Total saliva tested 163 0